Objective: To evaluate the role of newer agents in the management of atrial fibrillation (AF). Data sources: EMBASE and MEDLINE were searched (up to June 2012) combining medication names with ...

Dofetilide is under clinical development by Hyloris Pharmaceuticals and currently in Phase I for Atrial Flutter.

In that single-arm study, the rate of primary adverse events within 7 days of ablation was 2.9%, with the most common ...

The temporary pause follows reports of four cases of neurovascular events in the US external evaluation study.

He had a history of atrial fibrillation (AF) that initially occurred 2 years before in the context of streptococcal ...

Esophageal squamous cell carcinoma (ESCC) is a severe health threat, being a predominant subtype of esophageal cancer and ...

Pulsed field ablation (PFA) is emerging as an alternative, using non-thermal electric fields to target cardiac tissue while ...

THRV-1268 is under clinical development by Thryv Therapeutics and currently in Phase I for Atrial Fibrillation.

Looking back, Kokomo resident Mike Beatty knew he had something as a teenager, but he couldn’t put a name to it.

About 200,000 Louisiana residents are living with a heart condition called atrial fibrillation but there is a new treatment ...